1gene Overview

  • Founded
  • 2014

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $8.06M

  • Investors
  • 2

1gene General Information


Provider of gene testing services intended to serve the biotechnological sector in China. The company's services include health risk detection testing, tumor gene detection and tumor precision motoring, enabling physicians to get accurate results and treat their patients in an enhanced way.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • 15th Floor, Yuanfang Technology Center
  • 88 Jucai Road, Binjiang District
  • Hangzhou, Zhejiang
  • China
+86 0571 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

1gene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 24-Jun-2015 $8.06M 00.000 000.00 Completed Generating Revenue
1. Seed Round 21-Oct-2014 00000 00000 Completed Generating Revenue
To view 1gene’s complete valuation and funding history, request access »

1gene Executive Team (1)

Name Title Board Seat Contact Info
Junyi Wang President, Founder, Chairman, General Manager & Chief Executive Officer
To view 1gene’s complete executive team members history, request access »

1gene Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Hangzhou Everfine Photo-e-info Company Corporation Minority 000 0000 000000 0
Tisiwi Venture Capital Minority 000 0000 000000 0
To view 1gene’s complete investors history, request access »